Abstract
Atma Jaya Catholic University of Indonesia (AJCUI) COVID-19 Laboratory has become a reference testing site, which contributed to prevent the SARS-CoV-2 transmission in Indonesia. Through the LSSR and CARE, the Indonesian government has implemented moderate yet arguably successful policies to combat this pandemic. This study aims to assess and strengthen public health management while enhancing our understanding of the dynamics of COVID-19. We analyzed the correlation between policies enforced in controlling COVID-19 from July 2020–December 2022 to the positivity rate and viral intensity. AJCUI, DKI Jakarta, Indonesia demonstrated a similar trend in COVID-19 prevalence. Government policy on mobility restrictions has substantially reduced the positivity rate in Indonesia within the period of study. Our study interpreted that the Ct value in the positive case population of AJCUI data correlated positively with DKI Jakarta and Indonesia; subsequently, it has the potential to serve as an early warning for an anticipated wave. Despite the coverage of vaccines, AJCUI and DKI Jakarta positivity rates are shifting due to evolving virus variants. Altogether, the comprehensively recorded data would enable an understanding of COVID-19 dynamics, serve as a model for unprecedented disaster and public health management in general.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
